Court Divide Could Spur More Hatch-Waxman Venue Fights

A question that affects where drugmakers can sue their generic competitors has split district courts following the U.S. Supreme Court's landmark TC Heartland decision in May, likely giving rise to more...

Already a subscriber? Click here to view full article